Similar to This
HP appoints Emma Walmsley as CEO
HP appoints Emma Walmsley as CEO: The former GSK CEO will take over the leadership of HP on January 4, 2027. Interim CEO Bruce Broussard will then become ...
it-business.de/hp-ernennt-emma-walmsley-zur-ceo-a-316e531e3235a8bb5629c091ec16968a/
The UK’s pharma deal was vital – but the GSK boss is right about US ...
The UK’s pharma deal was vital – but the GSK boss is right about US dominance: It would be absurd to claim the UK has suddenly become a life-sciences leader ...
theguardian.com/business/nils-pratley-on-finance/2025/dec/11/uk-pharma-deal-gsk-us-pricing-tariffs
UK must reform drug pricing to become life sciences superpower ...
UK must reform drug pricing to become life sciences superpower, says GSK boss: Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can ...
theguardian.com/business/2025/oct/29/gsk-boss-britain-reform-drug-pricing-life-sciences-emma-walmsley
GSK chief doesn’t buy that the CEO role has become unsustainable: ‘There ...
GSK chief doesn’t buy that the CEO role has become unsustainable: ‘There are few things more obnoxious in life than CEOs complaining about how hard their life ...
fortune.com/2025/10/15/gsk-ceo-emma-walmsley-co-ceo-unsustainable-job/
UK firm GSK to pay $2.2bn over Zantac cancer claims
UK firm GSK to pay $2.2bn over Zantac cancer claims: UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases ...
saudigazette.com.sa/article/646122
GSK’s health is improving. Shame about the legal heartburn
GSK’s health is improving. Shame about the legal heartburn: Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share ...
theguardian.com/business/nils-pratley-on-finance/article/2024/jul/31/gsk-health-improving-shame-about-legal-heartburn
International Finance: Unilever Faces New Attack From Investors Over ...
International Finance: Unilever Faces New Attack From Investors Over Health Credentials
dailymaverick.co.za/article/2022-01-20-unilever-faces-new-attack-from-investors-over-health-credentials/
Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?
Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?: The boss’s plan to divide the pharma giant has support – but her own position may hinge on a crucial ...
theguardian.com/business/2021/jun/19/will-emma-walmsleys-radical-therapy-cure-glaxosmithkline
Trump vaccine leader Moncef Slaoui accused of sexual misconduct ...
Trump vaccine leader Moncef Slaoui accused of sexual misconduct, removed from medical company board
washingtonpost.com/business/2021/03/24/slaoui-glaxosmithkline-sexual-harassement/